• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC MEXICO S. DE R.L. DE CV EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC MEXICO S. DE R.L. DE CV EVOLUT FX VALVE; AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV Back to Search Results
Model Number EVOLUTFX-29
Medical Device Problem Code Patient Device Interaction Problem (4001)
Health Effect - Clinical Code Heart Block (4444)
Date of Event 05/08/2024
Type of Reportable Event Serious Injury
Event or Problem Description
It was reported that during the procedure involving a transcatheter aortic valve replacement, evidence of heart block presented.One day later, a permanent pacemaker was implanted due to complete heart block (chb).Per the physician, the chb was possibly related to the implant procedure, but not related to the valve.
 
Additional Manufacturer Narrative
Continuation of d10: product id d-evolutfx-2329; product lot number (0012160468); product type: 0195-heart valves; implant date: non-implantable device product id l-evolutfx-2329; product lot number (0012164310); product type: 0195-heart valves; implant date: non-implantable device.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Additional Manufacturer Narrative
Updated data: b5.A second paragraph was added.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
 
Event or Problem Description
It was reported that during the procedure involving a transcatheter aortic valve replacement, evidence of heart block presented.One day later, a permanent pacemaker was implanted due to complete heart block (chb).Per the physician, the chb was possibly related to the implant procedure, but not related to the valve.Additional information was received to report the chb resolved with sequelae on the same day of permanent pacemaker implant.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
EVOLUT FX VALVE
Common Device Name
AORTIC VALVE, PROSTHESIS, PERCUTANEOUSLY DELIV
Manufacturer (Section D)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX  22210
Manufacturer (Section G)
MEDTRONIC MEXICO S. DE R.L. DE CV
av. paseo del cucapah #10510
tijuana,bc 22210
MX   22210
Manufacturer Contact
alison sweeney
parkmore business park west
galway 
EI  
091708096
MDR Report Key24021986
Report Number9617601-2026-00190
Device Sequence Number10591008
Product Code NPT
UDI-Device Identifier00763000370701
UDI-Public(01)00763000370701(17)260312
Combination Product (Y/N)N
Initial Reporter StateCO
Initial Reporter CountryUS
PMA/510(K) Number
P130021
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2024
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Study,Health Professional,Company Representative
Initial Reporter Occupation Physician
Type of Report Initial,Followup
Report Date (Section B) 05/26/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date03/12/2026
Device Model NumberEVOLUTFX-29
Device Catalogue NumberEVOLUTFX-29
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 12/18/2025
Supplement Date Received by Manufacturer04/30/2026
Initial Report FDA Received Date01/09/2026
Supplement Report FDA Received Date05/26/2026
Date Device Manufactured03/12/2024
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
SEE H11...
Outcome Attributed to Adverse Event Life Threatening; Required Intervention;
Patient Age77 YR
Patient SexMale
Patient Weight75 KG
-
-